C12N 2760/18551
Methods of production or purification of viral material
C12N2760/18551 (Methods of production or purification of viral material) appears on 29 US grants and 36 published applications in this corpus.
Search patents in C12N- Granted patents
- 29
- Published applications
- 36
- Assignees
- 34
- Inventors
- 117
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 3 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 1 |
| 2005 | 0 | 2 |
| 2006 | 1 | 1 |
| 2007 | 1 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 2 |
| 2011 | 0 | 1 |
| 2012 | 0 | 3 |
| 2013 | 1 | 0 |
| 2014 | 2 | 0 |
| 2015 | 1 | 3 |
| 2016 | 2 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 2 |
| 2019 | 4 | 3 |
| 2020 | 2 | 2 |
| 2021 | 2 | 3 |
| 2022 | 0 | 1 |
| 2023 | 1 | 1 |
| 2024 | 2 | 6 |
| 2025 | 0 | 3 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Cell culture process for producing RSV F protein15 Sep 2026US 12,734,231 B2Pfizer Inc.
- Chimeric vectors27 Aug 2024US 12,071,632 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Recombinant respiratory syncytial virus strains comprising NS1 and NS2 gene shifts5 Mar 2024US 11,918,638 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Tim protein-bound carrier, methods for obtaining, removing and detecting extracellular membrane vesicles and viruses using said carrier, and kit including said carrier2 May 2023US 11,639,924 B2FUJIFILM Corporation
- Respiratory syncytial virus with a genomic deficiency complemented in trans6 Apr 2021US 10,967,014 B2De Staat der Nederlanden, vert. door de minister van VWS
- Plasmid dna purification methods1 May 2025US 2025/0137024 A1Glaxosmithkline Biologicals SA
- Modified vero cells and methods of using the same for virus production10 Apr 2025US 2025/0115881 A1Sanofi Pasteur Limited
- Rsv vaccine6 Feb 2025US 2025/0041400 A1AstraZeneca AB
- Chimeric vectors28 Nov 2024US 2024/0392317 A1The United States of America, as represented by the Secretary, Department of Health and Human Servic
- Respiratory virus combination vaccines4 Jul 2024US 2024/0216500 A1ModernaTX, Inc.
Most cited
By later US patents
- Production of virus and purification of viral envelope proteins for vaccine use7US 6,245,549 B1Connaught Laboratories Limited · 2001
- Respiratory syncytial virus with a genomic deficiency complemented in trans7US 9,107,939 B2De Staat der Nederlanden, vert. door de minister van VWS · 2015
- Method of producing a virus vaccine from an African green monkey kidney cell line4US 5,911,998 ADyncorp · 1999
- Subunit respiratory syncytial virus vaccine preparation4US 6,020,182 AConnaught Laboratories Limited · 2000
- Subunit respiratory syncytial virus vaccine preparation4US 6,309,649 B1Aventis Pasteur Limited · 2001